ArticleFrontiers in oncology2026

Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management.

Xiaofeng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.